1. PURPOSE AND SCOPE
To ensure the health and safety of its workforce, this COVID-19 Visitor Screening Policy and Procedure (“Policy”) establishes uniform guidelines for Buffalo Trace Distillery (“Buffalo Trace Distillery” “Company,” or “we”) and its affiliates to conduct verbal screening and temperature checks on Visitors during the COVID-19 global pandemic.
The primary symptoms of COVID-19 include fever, tiredness, and dry cough. Other reported symptoms may include shortness of breath, aches and pains, sore throat, nausea, runny nose, and loss of smell or taste. Based on current Centers for Disease Control and Prevention (“CDC”) and local public health information and guidance, public places may screen visitors for the limited purpose of evaluating the risk that visitor’s presence poses to others in the workplace as a result of the COVID-19 global pandemic. This policy is subject to change as guidance from the CDC and local public health information is revised.
Visitor Screening Upon Entry. For the duration of the pandemic, Visitors must pass through a COVID-19 screening area before entering Buffalo Trace Distillery. Visitors must wait six (6) feet apart from one another while in line. The Distillery will mark off the permissible distance. If a Visitor refuses to answer or refuses to submit to a temperature check, the individual will not be permitted to enter the Visitor Center.
Symptom-Related Questions. Visitors will answer basic symptom-related questions similar to the following:
If a Visitor answers YES to any of the above questions, OR the Visitor displays symptoms of COVID-19, then:
If the Visitor answers NO to any of the above questions, the Visitor will proceed to temperature screening.
Temperature Screening. Prior to entering a Sazerac Visitor Center, Visitors must be temperature screened. The Temperature Screening shall be administered in the least invasive way possible.
If a Visitor has a body temperature at or above 100.4 degrees Fahrenheit, then:
Visitors are only permitted to enter the Sazerac Visitor Center if the Screening Upon Entry process determines that the individual (1) is not symptomatic, and (2) does not have a fever at or above 100.4 degrees Fahrenheit.
Recording and Confidentiality. The Screening Upon Entry results will be recorded on a Screening Form and will contain the following information:
Sazerac's management will treat such documentation as confidential information and secure it accordingly. The data will only be accessible to key personnel who have a need to access such data.